Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo diterpene lactone meglumine injection in acute ischemic stroke
NCT05663307Phase 3Unknown
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jan 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Status: unknown.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05663307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05663307.